Benjamin A. Belinka
Algemeen Directeur bij Actinobac Biomed, Inc.
Profiel
Benjamin A.
Belinka is the founder of Ben Belinka LLC, Durin Technologies, Inc. He is currently the President & Chief Executive Officer at Actinobac Biomed, Inc. Previously, he worked as the Assistant Director-Research & Chemistry at Jazz Pharmaceuticals (EUSA Pharma USA), Inc., as a Principal at Virium Pharmaceuticals, Inc., as a Principal at Sandoz Pharmaceuticals Corp., and as a Vice President at Vectramed, Inc. He holds a doctorate degree from The State University of New York.
Actieve functies van Benjamin A. Belinka
| Bedrijven | Functie | Begin |
|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Algemeen Directeur | 17-07-2009 |
| Ben Belinka LLC | Oprichter | 27-04-2010 |
Eerdere bekende functies van Benjamin A. Belinka
| Bedrijven | Functie | Einde |
|---|---|---|
Durin Technologies, Inc.
 Durin Technologies, Inc. Medical/Nursing ServicesHealth Services Durin Technologies, Inc. engages in the development of blood tests to diagnose and monitor the progress of neurodegenerative diseases. The company was founded Robert G. Nagele in 2010 and is headquartered in Mullica Hill, NJ. | Algemeen Directeur | - |
Virium Pharmaceuticals, Inc.
 Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
| Vectramed, Inc. | Corporate Officer/Principal | - |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Hoofd Techniek/Wetenschap/O&O | 20-07-2009 |
Opleiding van Benjamin A. Belinka
| The State University of New York | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Virium Pharmaceuticals, Inc.
Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Health Technology |
| Sandoz Pharmaceuticals Corp. | |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
| Vectramed, Inc. | |
| Ben Belinka LLC | |
Durin Technologies, Inc.
Durin Technologies, Inc. Medical/Nursing ServicesHealth Services Durin Technologies, Inc. engages in the development of blood tests to diagnose and monitor the progress of neurodegenerative diseases. The company was founded Robert G. Nagele in 2010 and is headquartered in Mullica Hill, NJ. | Health Services |
